Christoffer A Hagemann
Overview
Explore the profile of Christoffer A Hagemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hagemann C, Gasbjerg L, Christensen M, Knop F
STAR Protoc
. 2023 Feb;
4(1):102070.
PMID: 36853704
Here, we present a protocol for a randomized, double-blind, placebo-controlled, crossover trial to evaluate the effects of a continuous intravenous infusion of a native liver-derived hormone, liver-expressed antimicrobial peptide 2...
2.
Hagemann C, Legart C, Mollerhoj M, Madsen M, Hansen H, Konig M, et al.
PLoS One
. 2022 Oct;
17(10):e0275901.
PMID: 36260611
Non-invasive biomarkers of non-alcoholic fatty liver disease (NAFLD) supporting diagnosis and monitoring disease progression are urgently needed. The present study aimed to establish a bioinformatics pipeline capable of defining and...
3.
Hagemann C, Jensen M, Holm S, Gasbjerg L, Byberg S, Skov-Jeppesen K, et al.
Cell Rep Med
. 2022 May;
3(4):100582.
PMID: 35492241
The gastric hormone ghrelin stimulates food intake and increases plasma glucose through activation of the growth hormone secretagogue receptor (GHSR). Liver-expressed antimicrobial peptide 2 (LEAP2) has been proposed to inhibit...
4.
Holm S, Husted A, Skov L, Morville T, Hagemann C, Jorsal T, et al.
Endocrinology
. 2022 Mar;
163(6).
PMID: 35352108
Introduction: Liver-expressed antimicrobial peptide-2 (LEAP2) is an endogenous ghrelin receptor antagonist, which is upregulated in the fed state and downregulated during fasting. We hypothesized that the ketone body beta-hydroxybutyrate (BHB)...
5.
Espersen C, Modin D, Hoffmann S, Hagemann C, Hagemann R, Olsen F, et al.
Int J Cardiovasc Imaging
. 2021 Aug;
38(1):131-140.
PMID: 34415451
Global longitudinal strain (GLS) has proven to be a powerful prognostic marker in various patient populations, but the prognostic value of layer-specific GLS has not yet been investigated in patients...
6.
Hagemann C, Zhang C, Hansen H, Jorsal T, Rigbolt K, Madsen M, et al.
J Clin Endocrinol Metab
. 2020 Nov;
106(2):e966-e981.
PMID: 33135737
Context: The mechanisms underlying Roux-en-Y gastric bypass (RYGB) surgery-induced weight loss and the immediate postoperative beneficial metabolic effects associated with the operation remain uncertain. Enteroendocrine cell (EEC) secretory function has...
7.
Hagemann R, Hoffmann S, Brainin P, Hagemann C, Fritz-Hansen T, Olsen F, et al.
Int J Cardiovasc Imaging
. 2020 May;
36(7):1249-1260.
PMID: 32405734
This study aimed to clarify the diagnostic and prognostic potential of strain rate in patients with suspected stable angina pectoris (SAP). Strain rate by 2-dimensional speckle tracking echocardiography (2DSTE) has...
8.
Hagemann C, Hoffmann S, Hagemann R, Fritz-Hansen T, Olsen F, Jorgensen P, et al.
Int J Cardiovasc Imaging
. 2019 Jun;
35(11):1989-1999.
PMID: 31227953
Novel software allows for layer-specific evaluation of myocardial strain by speckle tracking echocardiography (2DSTE). However, the potential of layer-specific strain at rest for diagnosing coronary artery disease (CAD) in patients...
9.
Laursen T, Hagemann C, Wei C, Kazankov K, Thomsen K, Knop F, et al.
World J Hepatol
. 2019 Mar;
11(2):138-149.
PMID: 30820265
Non-alcoholic fatty liver disease (NAFLD) is increasingly recognized as a significant liver disease, and it covers the disease spectrum from simple steatosis with a risk of development of non-alcoholic steatohepatitis...